Zacks Investment Research upgraded EndoChoice Holdings from a "hold" rating to a "buy" rating, according to MicroCap Magazine.
Here are four points:
1. Zacks presently has a $5.25 price target on EndoChoice stock.
2. EndoChoice has a 50-day moving average price of $4.78 and a 200-day moving average price of $8.50.
3. The company has a 12-month low of $3.70 and a 12-month high of $19.69.
4. The company's market cap is $124.72 million.